Powered by

Entest BioMedical Inc.'s Subsidiary Zander Therapeutics Announces Appointment of Dr. Thomas Donnelly to Serve as Senior Veterinary Advisor

Mar 9, 2017 - PR Newswire
Board and Executive Moves

Dr. Donnelly is an Internationally Recognized Animal Researcher, who theCompanyBelieves Will Play an Important Role in the Development ofZander'sNR2F6Small Molecule Drug Development Program for Veterinary Applications in Treating Canine Cancer and Arthritis in Animals 

Entest BioMedical Inc.'s (OTCPINK: ENTB) wholly owned subsidiary, Zander Therapeutics Inc., announced the appointment of Thomas Donnelly, DVM as its Senior Veterinarian Advisor. Dr. Donnelly is an internationally recognized

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox